Загрузка...

Factors Predicting Late Recurrence for Estrogen Receptor–Positive Breast Cancer

BACKGROUND: Adjuvant endocrine therapy beyond 5 years reduces recurrence in patients with estrogen receptor–positive breast cancer. We have previously shown that immunohistochemical markers (IHC4) and two gene expression profile tests (recurrence score [RS] and PAM50 risk of recurrence [ROR]) are as...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Sestak, Ivana, Dowsett, Mitch, Zabaglo, Lila, Lopez-Knowles, Elena, Ferree, Sean, Cowens, J. Wayne, Cuzick, Jack
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2013
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3787911/
https://ncbi.nlm.nih.gov/pubmed/24029245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djt244
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!